UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Journal of clinical oncology, 2009-02, Vol.27 (4), p.511-518

2009

Link zum Volltext

Verfügbarkeit prüfen

MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung

Clinical cancer research, 2015-02, Vol.21 (4), p.907-915

2015

Link zum Volltext

Verfügbarkeit prüfen

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

The lancet oncology, 2008-02, Vol.9 (2), p.105-116

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas

Haematologica (Roma), 2013-03, Vol.98 (3), p.364

2013

Link zum Volltext

Verfügbarkeit prüfen

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Cochrane database of systematic reviews, 2008-10 (4), p.CD003189

2008

Link zum Volltext

Verfügbarkeit prüfen

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)

Blood, 2008-01, Vol.111 (1), p.109-111

2008

Link zum Volltext

Verfügbarkeit prüfen

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study

BMC cancer, 2020-02, Vol.20 (1), p.155-155, Article 155

2020

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

Journal of clinical oncology, 2005-10, Vol.23 (28), p.7024-7031

2005

Link zum Volltext

Verfügbarkeit prüfen

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma

Critical reviews in oncology/hematology, 2011-03, Vol.77 (3), p.221-240

2011

Link zum Volltext

Verfügbarkeit prüfen

P679: SPOTLIGHT ON THE REAL‐WORLD TREATMENT OF CML PTS IN GERMANY: A RETROSPECTIVE SURVEY IN PRIVATE ONCOLOGY PRACTICES

HemaSphere, 2023-08, Vol.7 (S3), p.e4962270-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

Journal der Deutschen Dermatologischen Gesellschaft, 2008-05, Vol.6 (5), p.366-373

2008

Link zum Volltext

Verfügbarkeit prüfen

Rituximab maintenance therapy of follicular lymphoma in clinical practice

Cancer medicine (Malden, MA), 2018-07, Vol.7 (7), p.2903-2912

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry

Therapeutic advances in neurological disorders, 2016-05, Vol.9 (3), p.165-179

2016

Link zum Volltext

Verfügbarkeit prüfen

Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient

Journal of clinical virology, 2007-01, Vol.38 (1), p.83-86

2007

Link zum Volltext

Verfügbarkeit prüfen

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer

Case reports in oncology, 2017-07, Vol.10 (2), p.627-633

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?

Journal of clinical oncology, 2000-01, Vol.18 (2), p.332-339

2000

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 4 th Interim Analysis of the German Non-Interventional Trial RISA

Blood, 2021-11, Vol.138 (Supplement 1), p.3150-3150

2021

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal dosing of rituximab in male and female patients with DLBCL

Blood, 2014-01, Vol.123 (5), p.640-646

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations

Blood, 2022-11, Vol.140 (Supplement 1), p.2683-2684

2022

Link zum Volltext

Verfügbarkeit prüfen

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

The lancet. Gastroenterology & hepatology, 2021-02, Vol.6 (2), p.128-138

2021

Link zum Volltext

Verfügbarkeit prüfen

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Blood, 2008-01, Vol.111 (2), p.558-565

2008

Link zum Volltext

Verfügbarkeit prüfen

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Blood, 2012-04, Vol.119 (14), p.3276-3284

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(162)
Japanisch
(10)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(73)
Humans
(62)
Female
(39)
Male
(38)
Middle Aged
(37)
Hematology
(34)
Oncology
(31)
Adult
(30)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Aged
(29)
Treatment Outcome
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Hematologic And Hematopoietic Diseases
(18)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(17)
Rituximab
(17)
Antineoplastic Agents
(15)
Pharmacology. Drug Treatments
(15)
Aged, 80 And Over
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study

Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma

P679: SPOTLIGHT ON THE REAL‐WORLD TREATMENT OF CML PTS IN GERMANY: A RETROSPECTIVE SURVEY IN PRIVATE ONCOLOGY PRACTICES

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE‐BLIND, PLACEBO‐CONTROLLED CLL12 TRIAL

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

Rituximab maintenance therapy of follicular lymphoma in clinical practice

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry

Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer

Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 4 th Interim Analysis of the German Non-Interventional Trial RISA

Suboptimal dosing of rituximab in male and female patients with DLBCL

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Suchergebnisse filtern